Overview

Location:
Tel Aviv, Israel
Employees:
26-100
Business Model:
Licensing, B2B
Category:
Cyber Security, Biometrics, Behaviour Analysis
Geographic Markets:
World-Wide
Company Overview:

BioCatch provides banks and e-commerce companies with a technology to detect cyber threats and online fraud before it happens and to deliver solutions for mobile and web applications.

Using its own behavioral biometric authentication and threat detection technology, BioCatch analyzes bio-behavioral, cognitive and physiological factors to generate user profiles for banking and e-commerce sites thereby decreasing the amount of unsafe transactions to combat cyber threats.

Its technology is based upon what the company refers to as “invisible challenges” to monitor user behavior and conclude if the user is fraudulent or not.

BioCatch detects account takeovers, RAT, and malware attacks all using this behavioral and cognitive analytics approach.

Founders:

Avi Turgeman
Founder, CTO
Uri Rivner
Co-Founder

Leading Investors:

  • Blumberg Capital

  • OurCrowd

Financing Rounds:

Key Facts:

BioCatch has been granted 23 patents years, with 22 of them currently pending, along with 2 trademarks. Most of the company’s patents are regarding user authentication and communication control.

BioCatch has expanded its services across 6 countries and throughout banks and e-commerce sites.

A partnership between Nuance Communications and BioCatch was announced in February 2017 in order to provide BioCatch’s services as part of Nuance’s Security Suite and enhance their fraud detection system.

Similar Companies:

Lookout

Protecting individuals and enterprises, Lookout predicts and stops mobile attacks before they do harm.

Armor

The Leader in Active Cyber Defense

Cylance

Cylance is a global provider of cybersecurity products and services to solve the world's most difficult security problems.

Content & Privacy:

Confidentiality:
PrivatEquity, the online trading arena, provides a balance between the private shareholders (employees and former employees) need to protect its confidential information and the investor’s need for the transparency necessary to make an informed investment decision.
Content Sources:
All the information presented above was retrieved from public sources (media, company website, data from the registrar of private shareholder, etc.).
Responsibility:
PrivatEquity does not accept any responsibility or liability for the accuracy, content and reliability of this information.
Diversify your investments portfolio with investments that provide access to private securities and pre-IPO leading high-tech private growth companies.

The offering and selling of securities in this site is restricted only to 'Accredited Investors' as defined in the first supplement of the Israeli Securities Law, 5728-1968

Got A Question? Ask Us Now:

Full Name: *

Email: *

Telephone:

Your message:

Follow Us:
Design by: